U.S.-Israel Tussle Over IP Rights Continues; New Free Trade Policy Is Limited

The generic pharmaceutical industry won a victory when the United States agreed to loosen intellectual property restrictions in its free trade agreements. But the policy does not apply to every trading partner and some countries continue to battle against terms they say will delay the marketing of low-cost drugs